Sun.Nov 12, 2023

article thumbnail

Digitizing Healthcare: Can AI Augment Empathy and Compassion in Healthcare?

MedCity News

To digitize healthcare and lean on the emerging technologies is to find the opportunity within the relationship between machine and human to augment humans’ ability to be human – to empathize and provide the compassionate touch to care.

article thumbnail

Odysseys with Ivy Cohen

PM360

PM360 asked Ivy Cohen, President and CEO, Ivy Cohen Corporate Communications, about the place she just can’t stop returning to. Ivy and her mother join in to choose the finale winner. My Odyssey: For the past seven years (with a couple year COVID gap), my husband, mother, and I attend Amateur Night at The Apollo—The Grand Finale on the night before Thanksgiving.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Takeda Drug Wins First FDA Approval in Rare, Inherited Blood Clotting Disorder

MedCity News

Takeda Pharmaceutical enzyme replacement drug Adzynma is the first FDA-approved therapy for a rare blood disorder affecting fewer than 1,000 Americans. Our regulatory recap also includes the much-anticipated approval of an Eli Lilly weight loss drug and a crackdown on what the FTC says are improperly listed pharma product patents.

FDA 111
article thumbnail

Rethinking the Launch—Don’t Fall into the Recent Trend of Underwhelming Results

PM360

Here’s the fact: since the pandemic, launch revenues in pharma have declined. Doesn’t matter if it is specialty or primary care whether it’s the U.S. or the rest of the world, they’ve declined. The question is: What do you do to maximize the success of your launch? After a review of the professional literature and great advice from several colleagues in pharma, here are several things I would recommend.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

A Zip Code Could Determine a Baby’s Fate in the NICU and How Technology Can Change That

MedCity News

Digital tools like remote monitoring devices, virtual care, and clinical intelligence platforms – all can be leveraged to fill gaps in care in rural hospitals as it relates to care in neonatal intensive care units. In the hands of a collective many, they can be deployed to level the playing field in caring for babies needing special attention and to increase bandwidth and improve adherence to quality guidelines.

article thumbnail

AHA: Wegovy improves survival in outcomes trial

pharmaphorum

AHA: Wegovy improves survival in outcomes trial Phil.

110
110

More Trending

article thumbnail

One Size Doesn’t Fit All for Access to Emerging Markets

PM360

While the global biopharma industry retains its huge dependence on the U.S. market, emerging markets present great opportunities for biotech and pharmaceutical companies. Development—and in particular, urbanization—means these markets offer greater potential than in the past. These markets often have larger populations than more established markets and higher population growth.

article thumbnail

Important Factors Differentiating Prescription Versus OTC Hearing Aids

MedCity News

It is important to understand that the performance of over-the-counter hearing aids can vary widely from prescription hearing aids due to a number of factors.

article thumbnail

Uncovering the Hidden Gems within Your Datasets

PM360

Data clearly matters in pharma. For the fourth year in a row artificial intelligence (AI) and Big Data ranked as the most impactful technologies in the industry, according to GlobalData’s “The State of the Biopharmaceutical Industry – 2023” report, which includes feedback from 198 companies. On top of that, the life sciences analytic market is expected to surpass $45.1 billion by 2030, according to ReportLinker.

article thumbnail

Cardiovascular-Kidney-Metabolic Syndrome Requires a Collaborative Approach to Treatment

Pharmacy Times

The American Heart Association published a statement describing the cardiovascular-kidney-metabolic (CKM) construct, specifically highlighting treatment challenges for CKM syndrome.

58
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Two Key Questions About Data Analytics in 2023

PM360

PM360 asked data experts what hidden insights companies may already have if they just know how to look for it as well as the best way to get buy-in on predictive analytics or next best action recommendations. Specifically, we wanted to know: As we undergo a data revolution in terms of the volume of data now at our exposure and the tools to analyze it, what is the biggest unrealized potential hidden in a company’s data assets?

Sales 59
article thumbnail

Data Analytics in the Agency World

PM360

The pharmaceutical marketing landscape is fast-moving and ever-evolving. New entrants come into a therapeutic class, often with increased efficacy or safety, while older products lose patent exclusivity, changing the promotional landscape. Plus, the ways healthcare providers (HCPs) interact with both patients and pharmaceutical companies have seen significant changes.

article thumbnail

Reducing Abandonment on the Path to Prescription

PM360

Technological innovations and changes in consumer behavior over the past 10 years have reduced friction, saved time, and opened new options for consumers and patients seeking routine prescriptions and refills via telehealth. Let’s face it, most consumers seek convenience wherever they can find it. For routine healthcare, that often means skipping the doctor’s office if the individual can be qualified by an HCP via virtual care and then seamlessly receive the prescription (when medically appropri

article thumbnail

Navigating a Greener Path: Sustainable Digital Advertising in Pharma

PM360

Pharma brands are increasingly humanizing the patient journey today unlike ever before. The growing emphasis on more strategically aligning doctor data with patient advertising targeting is leading to better and more impactful experiences that more deeply consider the “why” behind how people approach their health. But for pharma marketers, aligning operations with the ethos of health, well-being, and responsibility shouldn’t end with serving the right ads to consumers.

Pharma 52
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

How to Thrive in the Wild West of New Targeting Techniques and Regulations

PM360

In the current regulatory landscape, pharmaceutical marketers may be looking back fondly on the days when HIPAA and HITECH were the only laws related to data privacy. But that landscape is changing fast, triggered largely by the California Consumer Privacy Act (CCPA). “California started, and just about every state in the union now is looking at some sort of legislation at the state level because HIPAA doesn’t cover everything that consumers are concerned with when it comes to privacy,” explains

article thumbnail

Odysseys with Kara Bissonnette

PM360

PM360 asked Kara Bissonnette, Marketing Manager, Saatchi & Saatchi Wellness, about the place she just can’t stop returning to. My Odyssey: Anyone who’s ever met me knows I rant and rave about the state I grew up in—Rhode Island. An idyllic little slice of the northeast, smallest state in the nation (yes state, not island) and best kept secret. You can’t drive more than 10 miles without catching a glimpse of the ocean (the state has over 400 miles of coastline, which is the basis of its epith